These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 12750289

  • 1. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 2. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW.
    J Biol Chem; 2005 Mar 18; 280(11):10047-54. PubMed ID: 15647279
    [Abstract] [Full Text] [Related]

  • 3. 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.
    Huang YC, Hung WC.
    J Cell Physiol; 2006 Nov 18; 209(2):363-9. PubMed ID: 16883603
    [Abstract] [Full Text] [Related]

  • 4. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 18; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T.
    Biochem Biophys Res Commun; 1997 Dec 08; 241(1):142-50. PubMed ID: 9405248
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 7. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H.
    Invest Ophthalmol Vis Sci; 2010 Feb 15; 51(2):679-85. PubMed ID: 19737884
    [Abstract] [Full Text] [Related]

  • 8. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Björkholm M, Henriksson M, Gruber A, Xu D.
    Exp Cell Res; 2002 Mar 10; 274(1):25-34. PubMed ID: 11855854
    [Abstract] [Full Text] [Related]

  • 9. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 10. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L, Sowa Y, Sakai T, Pardee AB.
    Oncogene; 2000 Nov 23; 19(50):5712-9. PubMed ID: 11126357
    [Abstract] [Full Text] [Related]

  • 11. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW.
    Cancer Res; 2001 Aug 15; 61(16):6239-47. PubMed ID: 11507078
    [Abstract] [Full Text] [Related]

  • 12. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H, Hasegawa T, Isobe K.
    J Cell Biochem; 1999 Jun 01; 73(3):291-302. PubMed ID: 10321829
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T.
    Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822
    [Abstract] [Full Text] [Related]

  • 14. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H, Wu X.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):860-7. PubMed ID: 15474507
    [Abstract] [Full Text] [Related]

  • 16. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y, Zhang X, Salmon M, Zehner ZE.
    Genes Cells; 2007 Aug 12; 12(8):905-18. PubMed ID: 17663720
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R, Alsarraj M, Wright KL, Muñoz-Antonia T.
    Oncogene; 2001 Oct 18; 20(47):6899-909. PubMed ID: 11687969
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells.
    Park SH, Lee SR, Kim BC, Cho EA, Patel SP, Kang HB, Sausville EA, Nakanishi O, Trepel JB, Lee BI, Kim SJ.
    J Biol Chem; 2002 Feb 15; 277(7):5168-74. PubMed ID: 11744689
    [Abstract] [Full Text] [Related]

  • 19. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer.
    Ullerås E, Miller SJ, Adam GI, Kanduri C, Wilcock AC, Franklin GC.
    Exp Cell Res; 2001 Nov 01; 270(2):188-98. PubMed ID: 11640883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.